Repurposing Drugs to Target the Diabetes Epidemic
- 1 May 2016
- journal article
- review article
- Published by Elsevier in Trends in Pharmacological Sciences
- Vol. 37 (5) , 379-389
Abstract
No abstract availableKeywords
Funding Information
- Australian Research Council (DP 11010396, FT120100371)
- National Health and Medical Research Council
- Diabetes Australia
This publication has 84 references indexed in Scilit:
- Molecular mechanism of action of metformin: old or new insights?Diabetologia, 2013
- Activation of AMPK by Bitter Melon Triterpenoids Involves CaMKKβPLOS ONE, 2013
- National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participantsThe Lancet, 2011
- Metformin inhibits hepatic gluconeogenesis in mice independently of the LKB1/AMPK pathway via a decrease in hepatic energy stateJournal of Clinical Investigation, 2010
- Colesevelam Hydrochloride Therapy in Patients With Type 2 Diabetes Mellitus Treated With MetforminArchives of internal medicine (1960), 2008
- Use of Salsalate to Target Inflammation in the Treatment of Insulin Resistance and Type 2 DiabetesClinical and Translational Science, 2008
- HSP72 protects against obesity-induced insulin resistanceProceedings of the National Academy of Sciences, 2008
- Berberine improves glucose metabolism through induction of glycolysisAmerican Journal of Physiology-Endocrinology and Metabolism, 2008
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- Prevention of fat-induced insulin resistance by salicylateJournal of Clinical Investigation, 2001